The content focuses heavily on pediatric drug safety, regulation, and respiratory illness in children. The most relevant courses will be those within **Pediatrics**, **Safe Prescribing**, and potentially **Pulmonology**.
Here is the modified HTML with strategic internal links:
The call for mandatory warning labels on cough syrups for children under two years echoes a critical concern in pediatric public health. Consequently, the Indian Academy of Pediatrics (IAP) National Respiratory Chapter Chairperson, Dr. Sanjiv Singh Rawat, emphasized that most cough syrups sold in India still lack these essential safety warnings. Over-the-counter (OTC) sales without age restrictions pose a serious risk of misuse, especially since parents often purchase these treatments without medical consultation. Addressing Cough Syrup Safety is a regulatory imperative, not just a medical one. Professionals focused on child health should review healthy child standards.
The Regulatory Failure Behind Child Deaths
Recent tragedies in Madhya Pradesh and Rajasthan brought national attention to pediatric cough medicine. However, Dr. Rawat clarified that the child deaths were not due to the standard formulation itself. Instead, contamination by harmful chemicals, such as Diethylene Glycol (DEG) or Ethylene Glycol (EG), caused these fatalities—a clear pharmaceutical manufacturing lapse and a major regulatory failure. Since the same standard formulations are otherwise safely sold across the country, the IAP insists that the government’s focus should be on regulatory oversight and quality control, vital aspects covered in the Certification Course In Safe Prescribing.
Why Cough Syrups Are Contraindicated for Toddlers
Cough syrups, especially those containing combination drugs like Dextromethorphan (DXM) or Promethazine, are generally not recommended for children below two years of age. These drugs can cause excessive drowsiness, which subsequently increases the risk of aspiration in young children. Furthermore, the Directorate General of Health Services (DGHS) recently advised against prescribing or dispensing these medications to children under two years and “not recommended” for children under five. Nevertheless, many Indian manufacturers continue to sell products without the mandated warning label, compounding the danger of OTC purchase and improper use. A deep dive into appropriate prescribing for this age group is crucial, as addressed in the International Post Graduate Program In Pediatrics.
A Global and National Call for Cough Syrup Safety
Paediatric pulmonologist Dr. Indu Khosla highlighted that certain cough syrups are readily available in Indian markets, yet they are restricted or unavailable abroad. This disparity underscores the need for stricter national standards. Therefore, the IAP is not requesting a complete ban on cough syrups; instead, they urge the Health Ministry to issue evidence-based guidelines and mandate a clear, bold warning label, such as “Not to be used in children below two years without prescription.” The IAP maintains that regulating OTC cough syrups, similar to how cigarette packets carry health warnings, is a necessary corrective action. Further learning on advanced respiratory care is available through the Certification Course In Asthma Diagnosis And Management.
Addressing Broader Pediatric Health Challenges
The 37th annual conference of the IAP National Respiratory Chapter, PedPulmocon 2025, also addressed the broader issue of preventable child deaths. Nagpur-based paediatrician Dr. Suchit Bagde raised concerns over the high incidence of respiratory illness fatalities. India records approximately 3.5 lakh pneumonia deaths in children annually—the highest figure globally. Major contributing factors include malnutrition, delayed access to treatment in remote areas, and the under-utilization of available vaccines. Consequently, improved drug regulation must be paired with comprehensive public health initiatives. Specialists can look towards advanced training in Paediatrics Speciality Courses.
Frequently Asked Questions
Q1: Why is IAP demanding specific warning labels on cough syrups?
The IAP demands a bold warning label—”Not to be used in children below two years without prescription”—because the absence of such warnings poses a serious risk of misuse during over-the-counter (OTC) sales. Standard cough syrup ingredients can cause excessive drowsiness and aspiration in young children.
Q2: Were the recent child deaths in MP and Rajasthan caused by the standard cough syrup formulation?
No. Dr. Rawat clarified that the deaths were caused by contamination of the cough syrup (e.g., Coldrif) with harmful chemicals like Diethylene Glycol (DEG) or Ethylene Glycol (EG). This was a manufacturing and regulatory lapse, not a failure of the standard drug formulation.
Q3: What non-pharmacological measures are recommended for cough in young children?
The DGHS and IAP recommend that most acute cough illnesses in young children are self-limiting. The first-line approach should be non-pharmacological measures, including adequate hydration, rest, saline nasal drops, and supportive care. For ongoing professional development in this domain, consider the Certification Course In Paediatrics.
References
- Doctors demand warning labels on cough syrups – ETHealthworld
- IAP advises rational prescription of medicines for children – The Hindu
- Doctors issue clarification on safe use of cough syrups in children – The New Indian Express
- Centre warns against cough syrups for children under 2 years after deaths in two states – newindianexpress.com
- Karnataka Bans Cough, Cold Syrups For Children Under 2 Years – NDTV
- After 11 child deaths, DGHS warns: ‘No cough syrups for kids under 2, not recommended for below 5’ – Mint
- After MP deaths, Haryana orders warning label on cough syrups – The Times of India
- Cough syrup check list: What parents should know – India Today
- Cough syrup advisory: Check names of three banned toxic syrups and five harmful ingredients parents should watch out for – The Economic Times
- Usage Of Banned Formula, No Certification: 350 Grave Violations At Coldrif Unit – YouTube
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.